Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin for depression: Considerations for clinical trial design

Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (84)

  1. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  2. Psilocybin and Mental Health-Don't Lose Control. 2018-01-01 · Expand citations
  3. Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults. 2017-12-01 · Expand citations
  4. Long-term follow-up of psilocybin-facilitated smoking cessation. 2017-01-01 · Expand citations
  5. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  6. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  7. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  8. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  9. Psychedelics not linked to mental health problems or suicidal behavior: a population study. 2015-03-01 · Expand citations
  10. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  11. Over 30 million psychedelic users in the United States. 2013-01-01 · Expand citations
  12. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  13. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  14. OpenAlex W1035028816
  15. OpenAlex W1730751745
  16. OpenAlex W1776258049
  17. OpenAlex W1908895882
  18. OpenAlex W1924546259
  19. OpenAlex W1964684482
  20. OpenAlex W1970133878
  21. OpenAlex W1978384112
  22. OpenAlex W1997161439
  23. OpenAlex W2002554882
  24. OpenAlex W2004762037
  25. OpenAlex W2017854344
  26. OpenAlex W2018351853
  27. OpenAlex W2018366064
  28. OpenAlex W2023081218
  29. OpenAlex W2023634568
  30. OpenAlex W2023687307
  31. OpenAlex W2032318019
  32. OpenAlex W2033784736
  33. OpenAlex W2034669884
  34. OpenAlex W2049695419
  35. OpenAlex W2055312975
  36. OpenAlex W2057880023
  37. OpenAlex W2063900798
  38. OpenAlex W2066671649
  39. OpenAlex W2083644336
  40. OpenAlex W2083894864
  41. OpenAlex W2084152792
  42. OpenAlex W2090339413
  43. OpenAlex W2094608167
  44. OpenAlex W2101646907
  45. OpenAlex W2109334244
  46. OpenAlex W2112249597
  47. OpenAlex W2113099805
  48. OpenAlex W2120460120
  49. OpenAlex W2124295269
  50. OpenAlex W2128603617
  51. OpenAlex W2139725402
  52. OpenAlex W2140018908
  53. OpenAlex W2142133137
  54. OpenAlex W2146236789
  55. OpenAlex W2148083007
  56. OpenAlex W2148796661
  57. OpenAlex W2153403353
  58. OpenAlex W2159011576
  59. OpenAlex W2169411569
  60. OpenAlex W2170904543
  61. OpenAlex W2171340584
  62. OpenAlex W2291794699
  63. OpenAlex W2296296811
  64. OpenAlex W2318643681
  65. OpenAlex W2319165603
  66. OpenAlex W2326537158
  67. OpenAlex W2340399189
  68. OpenAlex W2410368260
  69. OpenAlex W2428332025
  70. OpenAlex W2438144546
  71. OpenAlex W2480021183
  72. OpenAlex W2590652160
  73. OpenAlex W2757390367
  74. OpenAlex W2894431596
  75. OpenAlex W2897080393
  76. OpenAlex W2942667518
  77. OpenAlex W2944263526
  78. OpenAlex W2952169207
  79. OpenAlex W4240995428
  80. OpenAlex W4245499518
  81. OpenAlex W6637688905
  82. OpenAlex W6696590373
  83. OpenAlex W6703672616
  84. OpenAlex W6717913965

Cited by — these papers cite this paper (1)

  1. use of psilocybin in the treatment of psychiatric disorders - review 2023-08-15 · Expand citations